SlideShare a Scribd company logo
Get Homework/Assignment Done
Homeworkping.com
Homework Help
https://www.homeworkping.com/
Research Paper help
https://www.homeworkping.com/
Online Tutoring
https://www.homeworkping.com/
click here for freelancing tutoring sites
Ischemic
Stroke
Case Study
January 2014
1. Basis of selection of case
In the previous years, a Food and Nutrition Research Institute 1998 study, about
21 percent of adults aging from 20 years old and above have hypertension, (the single
most important risk factor for stroke and it causes about 50 per cent of ischemic strokes
and also increases the risk of hemorrhagic stroke) while a Philippine Health Statistics
1993 figure showed 28 deaths per 100 000 population caused by stroke.
Nowadays, still, stroke makes its way on top. Worldwide, stroke is the second-
leading cause of death after heart disease and is also a big contributor to disability. Due to
the increasing number of stroke cases annually and the expanding cases in the younger
generation, the government of the Philippines should emphasize primary and secondary
prevention strategies.
As we talk about prevention strategies, there is a great role for nurses/student
nurses, as well as for the rest of the medical team, comes in. Reading a case study and
coming up with a diagnosis is a good way for nursing students to test the knowledge
they've acquired in the classroom in a more realistic, clinical way. Writing case studies is
also a useful learning tool; it forces students to reflect on the entire course of treatment
for a patient, ranging from obtaining important information to diagnosis to treating the
medical condition. Increasing the knowledge regarding the disease process of stroke, the
proper assessment of the patient, correct intervention, effective health teaching, etc will
contribute a lot in improving prevention strategies.
2. Clarity of Objectives
General Objectives
After 2 hours of case presentation, the students will be able to obtain the
knowledge to enhance skills and to develop the attitude towards caring of the patient with
cases regarding ischemic stroke.
Specific Objectives
Specifically, this aims to
KNOWLEDGE
1. Explain the pathophysiology of ischemic stroke.
2. Identify the main cause of the disease.
3. Name the signs and symptoms of the disease manifested by the client.
SKILLS
1. Carry out independent and dependent intervention being done to the client
appropriately and with care.
2. Perform comprehensive nursing interventions based on the client’s priority needs.
3. Demonstrate proper approach used in clients with ischemic stroke.
ATTITUDES
1. Establish rapport to the client and folks.
2. Encourage the folks to cooperate to the intervention being performed.
3. Avoid promising words that might worsen the client’s condition.
3.1 ASESSMENT
A. PATIENT’S PROFILE
NAME: R. C.
AGE: 64 years old
SEX: Male
DATE OF BIRTH: June 28, 1949
ADDRESS: Barotac Viejo, Iloilo
OCCUPATION: National Referee, Retired Teacher
RELIGION: Roman Catholic
NATIONALITY: Filipino
ACTIVITY: Moderate Backrest
CC: Stiffening of extremities
DATE OF ADMISSION: December 12, 2013
DIAGNOSIS: T/C Brain Mets v/s restroke prob. Bleed,
S/P CVD with no residuals (2013) HCVD R/O Metastatic cause DM 2- NIR
S/P Thyroidectomy for thyroid CA Stage 1
PHYSICIAN: Dr. A
B. NURSING HISTORY
I. Reason for Seeking Care
Stiffening of extremities
II. Present Health History
Patient R.C. is 64 years old, male and married. He is a retired teacher and a national
referee.
8 months prior to admission, patient experienced episode of syncope. He was then
admitted at St. Paul’s Hospital for 1 month and managed as CVP, no residual noted.
1 month prior to admission, undocumented fever was noted. He was admitted at Don
Ramon Tugbang Medical Center and diagnosed to have Urinary Tract Infection.
On the day of admission, patient experienced generalized weakness and stiffening of
extremities. A complaint of dizziness was noted. He was responsive and slurring of speech is
noted. He was brought to Don Ramon Tugbang Medical Center and then referred at Iloilo
Mission Hospital.
III. Past Health History
It was known that he is hypertensive and have Diabetes Mellitus. He has many previous
hospitalizations. He was diagnosed to have thyroid cancer stage 1 back in 1986. He had
undergone radiation therapy and left thyroidectomy in the same year at Philippine General
Hospital. No known allergies.
Last December 2012, He underwent Cranial CT scan and CT scan with contrast. January 7,
2014, he again underwent cranial CT scan.
IV. Current Medication
For now, he has current medication such as Amlodopine 10mg/tab OD, Simvastatin 40 mg/tab
OD, Losartan 50 mg/tab 1 tab OD for his hypertension and Metformin 500 mg 1 tab OD for his
Diabetes Mellitus.
V. Lifestyle
He is non-smoker and non-alcoholic drinker. He is also an athletic person. As verbalized
by the wife, most of the time he ate carrots instead of rice.
VI. Family History
As verbalized by the wife, he has familial history of Hypertension and Diabetes Mellitus.
C. PHYSICAL ASESSMENT
VITAL SIGNS
R.C.’s temperature is 36.5 °C, pulse rate is 88 beats per minute, respiratory rate is 20
breaths per minute, and blood pressure is 180/100 mmHg.
GENERAL APPEARANCE
R.C. is a 64 year old male, a national referee and a retired teacher. Bedridden since the
day of admission. Ectomorph, well developed and appears to be at stated age. Well cleaned and
wears appropriate clothes. Difficulty or discomfort making laryngeal speech sounds or varying
volume, quality, or pitch of speech. Comprehends directions. Appears to be in distress.
SKIN
Brown in color, dry, and wrinkled due to old age.Peeling, scaly and flaky skin on heels of the
feet. Skin color differences among body areas and between sun-exposed and non-sun-exposed
areas. Darker skin around elbows and knees. Warm in temperature. Turgor resilience. Bilateral
symmetry. Hair present on scalp, lower face, nares, chest, legs, and pubic areas.
NAILS
Nails beds pink with varying opacity. Short, squoval, smooth, flat, with edges smooth and round,
Longitudinal ridging and beading. Hard and firm with uniform thickness. Well-groomed and
uniform without deformities. Good capillary refill.
HEAD AND FACE
Hair is short, black with minimal gray hairs, and distributed evenly. Hair strands are thin,
fine and silky. Head is midline. Skull normocephalic, symmetric and without deformities. Scalp
is intact and without lesions or mass noted. Temporal pulses palpable. No bruits. Presence of
beard on upper lip and chin. Presence of black heads on the nose. Presence of dimple at the right
side of the face.
EYES
Eyebrows are smooth, black in color and distributed evenly and in line with each other.
With mole noted on the left inner end of the brow.Superior eyelid covering a portion of iris when
open. Eyelashes are black, evenly distributed, present on both lids and turned outward.
Conjunctivae pink, sclera anecteric. Irides black. Pupils equal, round, and reactive to light and
accommodation.
EARS
Auricles in alignment, same color as facial skin.Firm and mobile, readily coiling from
position; non-tender.Absence of discharges.
NOSE
Nose in midline, no discharges or polyps, mucosa pink and moist, septum midline, patent
bilaterally. Conforms to face to color.Nares oval and symmetrically positioned. No sinus
tenderness to palpation. With O2 at 2Lpm via nasal cannula.
MOUTH AND OROPHARYNX
Lips symmetric vertically and horizontally at rest and moving.Dry, bluish purple, distinct
border between lips and facial skin. Teeth are stained yellow and absence of left lateral incisor.
Gingiva pink and moist. Tongue is midline, dull red in color and moist. No tremors and
fasciculation. Hard palate and soft palate are pinkish in color. Pharynx clear without erythema.
Uvula rises evenly.
NECK
Neck is straight and symmetrical. Trachea midline. Jugular vein distention noted. Carotid
pulse palpable.Cricoid cartilages smooth and moves during swallowing. Left thyroid palpable,
firm, and smooth; presence of slightly hypoechoic nodule.Absence of right thyroid lobe.
THORAX AND CHEST
Minimal increase in the anteroposterior diameter of chest.Thoracic expansion symmetric.
No adventitious breath sounds. Regular respiratory rate. Chest retraction noted. Apical pulse on
5th intercostals space. The areola and nipples are dark brown in color and no discharges noted.
ABDOMEN
Soft, flat and symmetrical. Uniform in color, no pigmentation and rashes noted. No
abdominal scars and masses. Active bowel sounds audible in four quadrants.
UPPER EXTREMITIES
Arms fair in color and symmetrical. No tenderness upon palpation of muscle and joints.
Unable to passively perform full range of motion at right affected hand; stiffness noted. Palms
are pale and warm. Radial and brachial pulses palpable.With PNSS 1L x 80cc/H infusing well at
left cephalic vein.
LOWER EXTREMITIES
Legs are fair in color and symmetrical. Muscles are firm and skin is slightly dry. Soles
are pale and warm to touch. Unable to passively perform full range of motion at right affected
leg. Popliteal and dorsalis pedis pulses palpable.
GENITO-ANAL AND GENITO-URINARY
Pubic hairs are present. No skin lesions, penile discharges and swelling noted. Urinated to
a moderate amount of yellowish colored urine.Defecated to a soft brown stool.
D. DIAGNOSTIC TEST
LABORATORY TEST RESULT NORMAL VALUES SIGNIFICANCE
URINALYSIS
 Color Pale straw
 Transparency Slightly Hazy
 Reaction 7.0
 Specific Gravity 1.015 1.010 – 1.025 NORMAL
 Sugar 1+
 Albumin Neg ( - )
 Pus cells 3.6 hpf
 Red Bloodcells 0.3 hpf
 Amorphous urates FEW
 Squamous Cells FEW
 Bacteria Occasional
 Mucus Threads FEW
 Yeast Cells NONE
HEMATOLOGY
 Hemoglobin 103 g/L 140 – 180 Anemia, bleeding, blood
dyscrasia
 Hematocrit 0.31 vol.fr. 0.42- 0.52 Anemia
 Red bloodcell count 3.77 x 10^ 12/L 4.7 – 6.1 Anemia, bleeding, bone marrow
failure, malnutrition
 White bloodcell count 14.98 x 10 ^9/ L 5.2 -12.4 Infection, Anemia, adrenal or
thyroid gland issues, immune
system disorder, inflammation,
tissue
damage, severe stress
 Segmenter 90% 50 – 70 infection, inflammation
 Stab 0 2-5
 Juvenile 0 0 - 1 Normal
 Basinophil 0 0.0 – 1.5 Normal
 Eosinophil 0 0 – 7 Normal
 Lymphocyte 9% 19 – 48 not significant
 Monocyte 1% 3.4 – 9 not significant
 Platelet Count 341 x 10^9/ L 130 – 400 Normal
 MCV 83 fl 80 – 94 Normal
 MCH 27 pq 27 – 31 Normal
 MCHC 33g/dL 33 – 37 Normal
 RDW 11.7% 11.5 – 14.5 Normal
 ESR 37 mm/ Hr 0 – 10 inflammation
IMMUNOLOGY
 CRP 48 mg/L <6- inflammation
 T3 95nmol/L 0.95 – 250 Normal
 T4 91.43 nmol/L 60 – 120 Normal
 TSH 0.88 u/ v/mL 0.25 – 5.0 Normal
Euthyroid: 0.25 – 5.0u/V/ml
Hypothyroid : greater than
7.0u/V/ml
Hyperthyroid: less than
0.15u/V/ml
 APTT 24.4 sec 24.0 – 35.0 Normal
 % Activity 99% 70-100 Normal
 Patient 13.1 sec 11.6- 16.0 Normal
 INR 1.00 -
CHEMISTRY
 Fastingbloodsugar 9.58 mmol/L 4.10 – 5.90 heart attack, stroke
 Cholesterol 3.44 mmol/L 1.30 – 5.2 Normal
 Triglycerides .94 mmol/L 0.17 – 1.70 Normal
 HDL 0.84 mmol/L .90 – 1.55 atherosclerosis, CVD
 LDL 2.17 mmol/L 0.0 – 3.9 Normal
 Uric Acid 178 mmol/L 160-430 Normal
 Calcium 2.05 mmol/L 2.12- 2.25 Hypocalcemia
ULTRASOUND
Thyroid Ultrasound:
 The right thyroidlobe is surgically absent. Theleft thyroidmeasures 3.73x 1.63 x 1.29cm ( LxWxAP ). The
isthmus is not thickenedandmeasures 0.21mmin thickness. Thereis a slightly hyporechoic nodule notedin the
inferior aspect of the left thyroid lobe measuring0.81x 0.71 x 0.53cm ( LxWxAP ). There is a cystic focus
notedat the junctionof the isthmus andleft thyroidlobe measuring0.46 x 0.46x 0.26cm ( LxWxAP ). A cystic
focus is also notedin the midportion ofthe thyroidlobe measuring0.24x 0.11cm ( WxAP ).
The surroundingsoft tissues andvascular structures are unremarkable.
No mass/enlargedcervical lymphnodes appreciated.
Remarks:
 Left thyroidnodule andcyst.
 S/P Right thyroidectomy.
CHESTX-RAY
ChestPA:
 Clear lungfield with no grossly evident active koch’s infiltrates
 Tracheamidline
 Intact costophrenicsinuses
 Smooth diaghragmatic leaves
 Cardiac silhouettenorenlargedtransversely
 Curvilinear calcific densitynotedat the aortic knob
 Rest of the visualizedsoft andosseous tissues appear
 Unremarkable
Impression:
 Atherosclerosis: Aorta
CTSCAN
 Plain andcontrast enhancedaxial tomographicsections of the headreveal inhomogeneously enhancinghypodensitywith gyral
enhancement at theright frontoparietal areas. Also note of enhancingisodense nodules lesions withsurroundingedema in the right
inferior frontal andright frontal periventricular areas.
There are small hypodensities onboth capsuloganghenic andbifrontoparietal periventricularareas.
The ventricles areenlarged.
The midline structures are displacedto theleft.
The cerebral sulci are effaced.
No abnormal extra-axial fluidcollectiondemonstrated.
No posterior fossa , brain stemandsellar region do not appear unusual.
The petromastoids, includedorbits andparancoal sinuses andthe bony calvarium are unremarkable.
Remarks:
 Right frontoparietalhypodensity withgyral enhancement.
 Right inferiorfrontal andright frontal periventricular enhancinglesions withsurroundingedema.
 Lacunar infarcts, bilateral capsuloganglionicbifrontoparietal periventricular areas.
 Leftwardsubfalcine herniation.
 Obstructive hydrocephalus.
Drug Therapy
Generic name:Valporic Acid
Classification: Anti Convulsant
Dosage:( Adult and children > 10 y.o )
= 10- 15 mg/kg/day PO Route: Oral
Therapeutic Actions:
 Mechanism of action not understood; Anti epileptic activity may be related to the
metabolism of inhibitory neurotransmitter, GABA.
Indications:
 Solo and adjunctive therapy in simple ( petit mal ) and complex absence seizure
 Acute treatment of manic episode associated with bipolar disorder
 Prophylaxis of migraine headache
Contraindication and Cautions:
 Contraindicated with hypersensitivity to valporic acid, hepatic disease or significant
hepatic impairment
 Use cautiously with children younger than 18 months; children younger than 2 y.o
Adverse Effects:
 CNS: Sedation, emotional upset, depression, psychosis, aggression, behavioral
deterioration, suicibility.
 SKIN: Hair loss, rash
 GI: Nausea, vomiting, indigestion, diarrhea, abdominal cramps, constipation.
 GU: Irregular menses, amenorrhea
 HEMATOLOGIC: Altered bleeding, bruising.
Nursing considerations:
 Products containing alcohol should be avoided.
 Give drug with food if GI upset occurs.
 Be aware that the patient maybe increased risk for suicidal ideation monitor accordingly.
Patient Teaching:
 Take this drug exactly as prescribed.
 Do not chew tablet or capsule before swallowing them.
 Do not discontinue this drug abruptly or change dosage.
 Avoid alcohol and sleep inducing drugs.
Generic name:Losartan Potassium
Classification:Angioten II Antagonist
Dosage:( Adult and children 6 yrs and older )
= Starting dose of 50 mg PO daily Route: Oral
Therapeutic Actions:
 Selectively blocks the binding of angiotensin II to specific tissue receptors found in the
vascular smooth muscle and adrenal gland.
Indications:
 Treatment of hypertension, done or combination with other hypertensive.
 Treatment of diabetic nephropathy.
 Reduction of risk of CVA in patients.
Contraindications and Cautions:
 Contraindicated in previous hypersensitivity.
 Pregnancy or lactation
 Reduce dosage with hepatic or renal impairment.
Adverse Effects:
 CNS: Headache, dizziness and insomnia
 CV: Hypertension
 SKIN: Rash and dry skin
 GI: Diarrhea, abdominal pain and nausea
 RESPIRATORY: Cough
 OTHER: Back pain, fever and gout
Nursing Considerations:
Assessment
 Hypersensitivity to Losartan
 Pregnant
 Lactation
Patient Teaching:
 Take drug without regard to meals
 May experience these side effects:
- Dizziness
- Headache
- Nausea and vomiting
 Report fever, chills and pregnant
Generic name:Metformin
Classification:Antidiabetic Agents
Drugs:( Adult and pediatric 10 – 16 y.o )
= 500 mg bid/ 250 mg bid Route: Oral
Therapeutic Reaction:
 Increase peripheral utilization of glucose and decrease hepatic glucose production.
Indications:
 Adjunct to diet to lower blood glucose with type 2 DM
Contraindication and Cautions:
 With allergy to metformin, heart failure, diabetes complicated by fever, severe trauma
and severe infection.
 Use cautiously with the elderly
Adverse Effects:
 ENDOCRINE: Hypoglycemia
 GI: Anorexia, nausea and vomiting
 HYPERSENSITIVITY: Allergic skin reaction
Nursing Considerations:
 Allergy to metformin
 Pregnancy
 Lactation
Patient Teaching:
 Monitor blood for glucose and ketones as prescribed.
 Do not use this drug during preganancy.
 Avoid using alcohol while taking this drug.
 Report fever, sore throat, unusual bleeading and bruising.
Other anti-diabetic drugs: Gliclazide, Sitagliptin
Generic name: Baclofen
Classification: Muscle relaxant
Dosage: 5 mg PO tid for 3 days Route: Oral
Therapeutic Actions:
 Inhibits both monosynaptic and polysynaptic spinal reflexes; CNS depressant
Indications:
 Alleviation of signs and symptoms of spasticity resulting from MS
 Spinal cord injuries and other spinal cord diseases
Contraindications and Cautions:
 Contraindicated in previous hyper sensitivity.
 With skeletal muscle spasm
 Use cautiously with strokes, cerebral palst, parkinson’s disease
 Lactation and pregnancy
Adverse Effects:
 CNS: Transient drowsiness, weakness, fatigue
 CV: Hypotension
 GI: Nausea, Constipation
 GU: Urinary frequency, dysuria
 OTHER: Rash, pruritus, ankle edema
Nursing Considerations:
 Discontinue drug if hypersensitivity reaction occur
 Lactation
 Evaluate therapeutic response
Patient Teachings:
 Take this drug exactly as prescribed
 Avoid alcohol
 Do not take this during pregnancy
Generic Name: Amlodipine
Classification:Antianginal; Antihypertensive; Calcium channel blocker
Dosage: Adult and Pediatric 6-17 y.o.
2.5-5 mg daily
Route: Oral
Therapeutic actions:
 Inhibits the movement of calcium ions across the membranes of cardiac cells; inhibits
transmembrane calcium flow, w/c result in depression of impulse formation in
specialized cardiac pacemaker cells, slowing velocity of conduction of the cardiac
impulse.
Indications:
 Angina pectoris due to coronary artery spasm(Prinzmetal’s
Variant angina)
 Essential hypertension
Contraindications and cautions:
 Contraindicated w/ allergy to amlodipine
 Use cautiously w/ heart failure
 Pregnancy
Adverse effects:
 CNS: Dizziness, headache, and fatigue
 CV: Peripheral edema
 Skin; Flushing, rash
 GI: Nausea, abdominal discomfort
Nursing Consideration:
 Administer drug w/out regards to meals
 Monitor BP carefully
Patient teachings:
 Take w/ meals if upset stomach occurs
 Report irregular heartbeat, shortness of breath, and constipation
Generic name: Diazepam 5 mg IV
Classification: Antiepileptic; Anxiolytic
Dosage: Usual dosage is 2-20 mg IM/IV
Route: IM/IV
Therapeutic actions:
 Acts mainly as the limbic system and reticular formation; may act in spinal cord and at
supraspinal sites to produce skeletal muscle relaxation
Indications:
 Management of anxiety d/o
 Acute alcohol withdrawal
 Muscle relaxant
Contraindications and cautions:
 Contraindicated w/ hypersensitivity to benzodiazepines
 Use cautiously w/ elderly, impaired renal function
Adverse effects:
 CNS: Sedation, depression, fatigue, and restlessness
 CV: Bradycardia, CV collapse, and hypertension
 Skin: Rash and dermatitis
 GI: Constipation and diarrhea
 GU: Urinary retention
 Hematologic: Decreased Hct
 Other: Phlebitis and thrombosis in IV site, fever, diaphoresis, and muscular disturbances
Nursing considerations:
 Hypersensitivity to benzodiazepines
 Pregnancy and lactation
 Carefully monitor P, BP, respiration, during IV administration
Patient teachings:
 Take this drug exactly as prescribed
 Tell patient to report drowsiness, and weakness
Generic name: Mannitol
Classification: Osmotic; Urinary irrigant
Dosage: 50-200g/day
Route: IV
Therapeutic actions:
 Elevates the osmolarity of the glomerular filtrate, thereby hindering the reabsortion of
water leading to a loss of water, sodium, chloride: creates an osmotic gradient in the eye
between plasma and ocular fluids thereby reducing IOP.
Indications:
 Prevention and treatment of oliguric phase of renal failure
 Promotion of urinary excretion of toxic substances
 Irrigant in transurethral prostatic resection
Contraindications and cautions:
 Contraindicated w/ anuria due to severe renal disease
 Use cautiously w/ pulmonary congestion, dehydration, heart failure
 Lactation
 Pregnancy
Adverse effects:
 CNS: Dizziness, headache , blurred vision, SEIZURES
 CV: Hypertension, edema, thrombophlebitis and chest pain
 Skin: Skin necrosis w/ infiltration
 GI: Nausea, dry mouth
 GU: Diuresis, urine retention
 Hematologic: Fluid and electrolyte imbalance
 Respiratory: Pulmonary congestion
Nursing Considerations:
 Do not expose solution to low temp crystallization may occur
 Make sure infusion set contains a filter if giving concentrated mannitol
 Monitor serum electrolytes periodically w/ prolonged therapy
Patient teachings:
 Patient may experience these side effects: Increased urination, GI upset, dry mouth,
headache, blurred vision- ask for assistance
 Report difficulty of breathing, pain at the IV site and chest pain
Generic name: Simvastatin
Classification:Antihyperlipidemic
Dosage: 20-40 up to 80 mg PO daily in the evening
Route: Oral
Therapeutic actions:
 Inhibits HMG-CoA reductase, the enzyme that catalyze the first step in the cholesterol
synthesis pathway
Indications:
 To reduce the risk of coronary disease
 Treatment of patients w/ isolated hyper triglyceridemia
 Treatment of type III hyperlipoproteinemia
Contraindications and cautions:
 Contraindicated w/ allergy to simvastatin
 Use cautiously w/ impaired hepatic and renal function
 Cataracts
Adverse effects:
 CNS: Headache, sleep disturbances
 GI: Flatulence, diarrhea, abdominal cramps, constipation, nausea, heartburn, LIVER
FAILURE
 Respiratory: Sinusitis
 Other: ACUTE RENAL FAILURE, myalgia
Nursing considerations:
 Allergy to simvastasin
 Give in evening; highest rate of cholesterol synthesis are bet midnight and 5 am
 Advise patient that this drug cannot be taken during pregnancy
Patient teachings:
 Take drug in the evening
 Patient may experience these side effects: Nausea, headache, muscle and joint pains,
sensitivity to light
 Report severe GI upset, changes in vision, unusual bleeding/bruising, dark urine or light
colored stool, fever, muscle pain or soreness
E. Pathophysiology
Stroke or cerebrovascular accident also known as the brain attack is a vascular disorder
that injures the brain function. Stroke remains one of the leading causes of mortality and
morbidity. The term brain attack has become a popular substitute for stroke, with the intent of
equating stroke with a heart attack in terms of the timetable associated with the development of
neurologic deficits and the need for prompt emergency treatment.
A brain attack is a sudden impairment of cerebral circulation in one or more blood
vessels. It occurs when a blood clot blocks the blood flow in a vessel or artery or when a blood
vessel breaks, interrupting blood flow to an area of the brain. Regardless of the cause, the
underlying event is deprivation of oxygen and nutrients. Normally, if the arteries become
blocked, autoregulatory mechanisms help maintain cerebral circulation until collateral circulation
develops to deliver blood to the affected area. If the compensatory mechanism becomes
overworked, or if cerebral blood flow remains impaired for more than a few minutes, oxygen
deprivation leads to infarction of brain tissue. Stroke interrupts or diminishes oxygen supply and
commonly causes serious damage or necrosis in the brain tissues. When either of these things
happens, brain cells begin to die.
When brain cells die during a stroke, abilities controlled by that area of the brain are lost.
These include functions such as speech, movement, and memory. The specific abilities lost or
affected depend on the location of the stroke and its severity.
There are two types of “brain attacks” – ischemic and hemorrhagic. With ischemic
strokes, a blood clot blocks or plugs a blood vessel in the brain. With hemorrhagic strokes, a
blood vessel in the brain breaks or ruptures.
An ischemic stroke can occur in several ways – embolic, thrombotic, Transient ischemic
attack, and lacunar infarcts. Embolic stroke occurs when a blood clots forms in the body (usually
the heart) and travels through the blood stream to the brain. Once in the brain, the clot eventually
travels to a blood vessel small enough to blocks its passage. The clot lodges there, blocking the
blood vessel causing a stroke. In the thrombotic stroke, blood flow is impaired because of the
blockage to one or more arteries supplying blood in the brain. Blood-clot strokes can also happen
as the result of unhealthy blood vessels clogged with the build up with fatty acids and
cholesterol. So your body reacts in these injuries just as it would if you were bleeding from a
wound- it responds by forming clots. Transient ischemic attacks, or TIAs, are brief episodes of
stroke symptoms resulting from temporary interruptions of blood flow to the brain. It can last
anywhere from a few seconds up to 24 hours. Lacunar infarcts are small (1.5 to 2.0 cm) to very
small (3 to 4 mm) infarcts located in the deeper noncortical parts of the brain or in the brain
stem. They are found in the territory of single deep penetrating arteries supplying the internal
capsule, basal ganglia, or brain stem. They result from occlusion of the smaller branches of large
cerebral arteries, commonly the middle cerebral and posterior cerebral arteries and less
commonly the anterior cerebral, vertebral, or basilar arteries. In the process of healing, lacunar
infarcts leave behind small cavities, or lacuna. Six basic causes of lacunar infarcts have been
proposed: embolism, hypertension, small-vessel occlusive disease, hematologic abnormalities,
small intracranial haemorrhages, and vasospasm. Because of their size and location, lacunar
infarcts do not usually cause profound deficits such as aphasia or apracticagnosia of the minor
hemisphere. Instead, they often produce syndromes such as pure motor hemiplegia, pure sensory
hemiplegia, and dysarthria with the clumsy hand syndrome.
Overview
The Neurological System is divided into two major parts: the Central Nervous System
(CNS) and the Peripheral Nervous System (PNS).
The Central Nervous System is the body’s information headquarters, ultimately
regulating nearly all body functions. It CNS includes the brain and spinal cord.
The brain processes incoming information from within the body, and outside the body by
way of the sensory nerves of sight, touch, smell, sound, and taste. In other words, the brain is
where all thinking and decision-making takes place.
The spinal cord is the main pathway for information connecting the brain and peripheral
nervous system. Electrical impulses travel through the nerves and allow the brain to
communicate with the rest of the body.
The Peripheral Nervous System is responsible for the remainder of the body. It includes
cranial nerves (nerves emerging from the brain), spinal nerves (nerves emerging from the spinal
cord) and all the major sense organs.
The PNS is divided into the somatic (SNS) and autonomic nervous system (ANS).
The Somatic Nervous System (SNS) is responsible for all muscular activities that we
consider voluntary or that are within our conscious control.
The Autonomic Nervous System (ANS) is responsible for all activities that occur
automatically and involuntarily, such as breathing, muscle contractions within the digestive
system, and heartbeat.
The ANS is further divided into two- the sympathetic and parasympathetic system.
The Sympathetic System stimulates cell and organ function. It is activated by a perceived
danger or threat: by very strong emotions such as fear, anger or excitement; by intense exercise;
or when under large amounts of stress.
The Parasympathetic System inhibits cell and organ function. It slows down heart rate,
resumes digestion, and increases relaxation throughout the body.
The brain is the center of our body functioning. Once it is injured the total functioning of our
body will be affected. Physical activities are hampered and other vital organs will also be
affected as well. Once vital organs are not in their optimum functioning, it will aggravate the
seriousness of the condition of the patient.
Space – occupying blood
clots put more pressure in
the brain tissues
The ruptured cerebral
The regulatorymechanisms
of the brain attempt to
maintain equilibrium by
increasing BP and ICP.
Due to thrombosis, or
embolism, someneuronsdie
because of lack of oxygen
and nutrients
Hemorrhagic
Infarction of the Cerebral Vessels known as
Stroke
Tissue injury triggers an
inflammatory response
whichincreasesintracranial
pressure.
The injury disrupts
metabolism leading to
changes in ionic transport,
localized acidosis, and free
radical formation
Calcium,Sodium,water
accumulate inthe injured
F. Prioritizing Nursing Diagnosis
1. Ineffective Cerebral Tissue Perfusion related to cerebral edema as evidenced by altered
level of consciousness, stiffening of extremities, slurred speech
2. Impaired Physical Mobility r/t neuromuscular/musculoskeletal impairment
3. Self-Care Deficit r/t impaired mobility status
4. Disturbed Sensory Perception r/t altered sensory perception
5. Impaired Verbal Communication r/t decreased circulation to the brain
Cues Nursing Diagnosis Outcome Criteria Nursing Intervention Rationale Evaluation Discharge Planning
Subjective:
“ Budlayan siya
maghulag kag
maluya na ang
tuo nga parti
sang iya lawas.
Nabudlayan sya
maghambal daw
indi
maintindihan.”
as verbalized by
the folk.
Objective:
 T–36.5
 P - 88
 R - 22
 BP – 180/100
 GCS – 11
 Stiffening of
extremities
 Slurred
speech
 Ineffective
Cerebral
Tissue
Perfusion
related to
cerebral
edema as
evidenced by
altered level of
consciousness,
stiffening of
extremities,
slurred speech
Short Term:
After 8 hours of
effective nursing
intervention the
patient will be able
to:
1. Demonstrate
stable vital
signs.
2. Prevent /
minimize
complications.
3. Daily needs are
met either by
himself or
others.
4. Be free from
injury and fall
Long Term:
After 2 weeks of
effective nursing
intervention the
patient will be able
to:
1. Maintain
Independent:
1. Determine factors
related to individual
situation /decreased
cerebral perfusion.
2. Monitor/document
neurological status
frequently and
compare with
baseline.
3. Monitor vital signs.
4. Provide safety
measures
5. Evaluate pupils,
noting size, shape,
equality, light
 Influences choice of
interventions.
 Assesses trends in level
of consciousness
(LOC) and useful in
determining location,
extent, and
progression/resolution
of CNS damage. May
also reveal presence of
TIA, which may warn
of impending
thrombotic CVA.
 Monitor Alterations
 Prevent falls and injury
 Pupil reactions are
regulated by the
oculomotor (III) cranial
PARTIALLY
MET
Short Term:
After 8 hours of
effective nursing
intervention the
patient was
partially able to:
1. Demonstrate
stable vital
signs.
2. Prevent /
minimize
complications.
3. Daily needs are
met either by
himself or
others.
4. Free from
injury and fall
Long Term:
After 2 weeks of
effective nursing
intervention the
M – Instruct the
folks and the
patient to take
drugs as ordered.
Emphasize the
importance of
taking the drugs
at the right timing
of intake and
right dosage.
Explain to
patient/folks the
adverse effects of
the drugs.
E –
Provide/maintain
stress free
environment for
the client to
lessen discomfort.
T – Instruct
patient to perform
exercise treatment
given by physical
usual/improved
level of
consciousness,
cognition, and
motor/sensory
function.
2. Increased
cerebral
function and
decrease
neurological
deficits.
reactivity.
6. Assess higher
functions, including
speech, if patient is
alert.
7. Position with head
slightly elevated
and in neutral
position.
nerve and are useful in
determining whether
the brainstem is intact.
Pupil size/equality is
determined by balance
between
parasympathetic and
sympathetic enervation.
Response to light
reflects combined
function of the optic
(II) and oculomotor
(III) cranial nerves
 Changes in cognition
and speech content are
an indicator of
location/degree of
cerebral involvement
and may indicate
deterioration/increased
ICP.
 Reduces arterial
pressure by promoting
venous drainage and
may improve cerebral
patient was
partially able to:
1. Maintain
usual/improved
level of
consciousness,
cognition, and
motor/sensory
function.
2.Increased
cerebral
function and
decrease
neurological
deficits.
therapist. Advice
folks to assist
patient.
H – Instruct folks
to place patient
on moderate
backrest.
Encourage active
ROM for
unaffected
extremities and
perform passive
ROM for affected
extremities.
O – Explain to the
patient and folks
the importance of
keeping follow-
up appointments
with health care
providers and to
report any
untoward signs
and symptoms.
8. Maintain bedrest;
provide quiet
environment;
restrict
visitors/activities as
indicated. Provide
rest periods
between care
activities, limit
duration of
procedures.
Dependent:
1. Administer oxygen
at 2 Lpm as
ordered.
2. Administer the
following as
ordered:
-Baclofen1tab BID
and ValproicAcid
-Mannitol
circulation/perfusion
 Continual
stimulation/activity can
increase ICP. Absolute
rest and quiet may be
needed to prevent
rebleeding in the case
of hemorrhage.
 Reduces hypoxemia,
which can cause
cerebral vasodilation
and increase
pressure/edema
formation.
 For skeletal muscle
spasticity of spinal
&cerebral origin
D – Instruct the
patient/folks to
follow the diet
intended for the
patient. Healthy
and rich in
vitamins and
minerals.
Collaborate with
the dietician.
S – Encourage
folks to provide
physical,
emotional,
financial, and
spiritual support
to the patient.
25cc IV q8H
-Levetriacetam
500mg 1tab OD
-Losartan
50mg/tab 1tab OD
-Citicoline 500mg
1tab BID
-Amlodipine 20mg
1tab OD
-Simvastatin
40mg/tab 1tab OD
 To increase urine flow
in patients w/ acute
renal failure, reduce
raised intracranial
pressure & treat
cerebral edema.
 Adjunctive therapy in
the treatment of partial
seizures w/ or w/o
secondary
generalization.
 To manage HTN
 To treat
cerebrovascular
disorders including
ischemic stroke,
Parkinsonism & head
injury.
 To manage HTN &
angina pectoris.
 To treatment
hyperlipidemia;
prophylaxis in
hypercholesterolemic
patients w/ ischemic
heart disease.
205804404 ischemic-stroke-case-study

More Related Content

What's hot

Case presentation on hemiplegia
Case presentation on hemiplegiaCase presentation on hemiplegia
Case presentation on hemiplegia
Vigneswari Paladugu
 
Nephrotic Syndrome Case Presentation
Nephrotic Syndrome Case PresentationNephrotic Syndrome Case Presentation
Nephrotic Syndrome Case Presentation
Dr. Anick Saha Shuvo
 
Heart Failure (Case Presentation)
Heart Failure (Case Presentation)Heart Failure (Case Presentation)
Heart Failure (Case Presentation)
Raghad AlDuhaylib
 
a case presentation on diabetic foot/ case study on diabetic foot.
a case presentation on diabetic foot/ case study on diabetic foot.a case presentation on diabetic foot/ case study on diabetic foot.
a case presentation on diabetic foot/ case study on diabetic foot.
martinshaji
 
CASE PRESENTATION ON CVA STROKE
CASE PRESENTATION ON CVA STROKECASE PRESENTATION ON CVA STROKE
CASE PRESENTATION ON CVA STROKE
DR. METI.BHARATH KUMAR
 
Pediatric case presentation (congenital heart disease- PDA)
Pediatric case presentation (congenital heart disease- PDA)Pediatric case presentation (congenital heart disease- PDA)
Pediatric case presentation (congenital heart disease- PDA)
sakib_lostvalley
 
A case study on septic arthritis
A case study on septic arthritis A case study on septic arthritis
A case study on septic arthritis
martinshaji
 
Case study hypertension presentation show
Case study  hypertension presentation showCase study  hypertension presentation show
Case study hypertension presentation show
Kern Rocke
 
Case Presentation: Hypertension (A case on refusal of Evidence Based Medicine)
Case Presentation: Hypertension (A case on refusal of Evidence Based Medicine)Case Presentation: Hypertension (A case on refusal of Evidence Based Medicine)
Case Presentation: Hypertension (A case on refusal of Evidence Based Medicine)
Dr. Aryan (Anish Dhakal)
 
Intracerebral Hemorrhage Case presentation
Intracerebral Hemorrhage Case presentationIntracerebral Hemorrhage Case presentation
Intracerebral Hemorrhage Case presentation
Usama Ragab
 
A case study on anemia with congestive heart failure
A case study on anemia with congestive heart failureA case study on anemia with congestive heart failure
A case study on anemia with congestive heart failure
martinshaji
 
Case Presentation on Appendicitis.
Case Presentation on Appendicitis.Case Presentation on Appendicitis.
Case Presentation on Appendicitis.
Dr.Saroj Poudel
 
A case study on emphysematous pyelonephritis
A case study on emphysematous pyelonephritisA case study on emphysematous pyelonephritis
A case study on emphysematous pyelonephritis
Anisha Ebens
 
Neurology Case presentation: CVA ICH
Neurology Case presentation: CVA ICHNeurology Case presentation: CVA ICH
Neurology Case presentation: CVA ICH
Pranabesh Chakraborti
 
Case Presentation Infectious Diseases
Case Presentation Infectious DiseasesCase Presentation Infectious Diseases
Case Presentation Infectious Diseases
KhalafAlGhamdi
 
Case Presentation on Epilepsy
Case Presentation on EpilepsyCase Presentation on Epilepsy
Case Presentation on Epilepsy
DR. METI.BHARATH KUMAR
 
6. Acute Gastroenteritis
6. Acute Gastroenteritis6. Acute Gastroenteritis
6. Acute GastroenteritisWhiteraven68
 

What's hot (20)

Case presentation on hemiplegia
Case presentation on hemiplegiaCase presentation on hemiplegia
Case presentation on hemiplegia
 
Nephrotic Syndrome Case Presentation
Nephrotic Syndrome Case PresentationNephrotic Syndrome Case Presentation
Nephrotic Syndrome Case Presentation
 
Heart Failure (Case Presentation)
Heart Failure (Case Presentation)Heart Failure (Case Presentation)
Heart Failure (Case Presentation)
 
a case presentation on diabetic foot/ case study on diabetic foot.
a case presentation on diabetic foot/ case study on diabetic foot.a case presentation on diabetic foot/ case study on diabetic foot.
a case presentation on diabetic foot/ case study on diabetic foot.
 
CASE PRESENTATION ON CVA STROKE
CASE PRESENTATION ON CVA STROKECASE PRESENTATION ON CVA STROKE
CASE PRESENTATION ON CVA STROKE
 
Pediatric case presentation (congenital heart disease- PDA)
Pediatric case presentation (congenital heart disease- PDA)Pediatric case presentation (congenital heart disease- PDA)
Pediatric case presentation (congenital heart disease- PDA)
 
A case study on septic arthritis
A case study on septic arthritis A case study on septic arthritis
A case study on septic arthritis
 
An Interesting Case of Seizure
An Interesting Case of SeizureAn Interesting Case of Seizure
An Interesting Case of Seizure
 
A Case of Acute Kidney Injury (ARF)
A Case of Acute Kidney Injury (ARF)A Case of Acute Kidney Injury (ARF)
A Case of Acute Kidney Injury (ARF)
 
Case study hypertension presentation show
Case study  hypertension presentation showCase study  hypertension presentation show
Case study hypertension presentation show
 
Case Presentation: Hypertension (A case on refusal of Evidence Based Medicine)
Case Presentation: Hypertension (A case on refusal of Evidence Based Medicine)Case Presentation: Hypertension (A case on refusal of Evidence Based Medicine)
Case Presentation: Hypertension (A case on refusal of Evidence Based Medicine)
 
Intracerebral Hemorrhage Case presentation
Intracerebral Hemorrhage Case presentationIntracerebral Hemorrhage Case presentation
Intracerebral Hemorrhage Case presentation
 
A case study on anemia with congestive heart failure
A case study on anemia with congestive heart failureA case study on anemia with congestive heart failure
A case study on anemia with congestive heart failure
 
A Case of DVT for Discussion
A Case of DVT for DiscussionA Case of DVT for Discussion
A Case of DVT for Discussion
 
Case Presentation on Appendicitis.
Case Presentation on Appendicitis.Case Presentation on Appendicitis.
Case Presentation on Appendicitis.
 
A case study on emphysematous pyelonephritis
A case study on emphysematous pyelonephritisA case study on emphysematous pyelonephritis
A case study on emphysematous pyelonephritis
 
Neurology Case presentation: CVA ICH
Neurology Case presentation: CVA ICHNeurology Case presentation: CVA ICH
Neurology Case presentation: CVA ICH
 
Case Presentation Infectious Diseases
Case Presentation Infectious DiseasesCase Presentation Infectious Diseases
Case Presentation Infectious Diseases
 
Case Presentation on Epilepsy
Case Presentation on EpilepsyCase Presentation on Epilepsy
Case Presentation on Epilepsy
 
6. Acute Gastroenteritis
6. Acute Gastroenteritis6. Acute Gastroenteritis
6. Acute Gastroenteritis
 

Viewers also liked

Medical case report_ravi_chang_final
Medical case report_ravi_chang_finalMedical case report_ravi_chang_final
Medical case report_ravi_chang_finalBhagyashri Shinde
 
Ischemic and hemorrhagic stroke
Ischemic and hemorrhagic strokeIschemic and hemorrhagic stroke
Ischemic and hemorrhagic stroke
Gauhar Azeem
 
ischemic stroke
ischemic strokeischemic stroke
ischemic stroke
nadoy1122
 
Ischemic Stroke Subclassification, An Asian Viewpoint
Ischemic Stroke Subclassification, An Asian ViewpointIschemic Stroke Subclassification, An Asian Viewpoint
Ischemic Stroke Subclassification, An Asian Viewpoint
Ersifa Fatimah
 
Hemorrhagic stroke final final
Hemorrhagic stroke   final finalHemorrhagic stroke   final final
Hemorrhagic stroke final finalR C
 
Right MCA Ischemic Stroke with Left Hemiparesis
Right MCA Ischemic Stroke with Left HemiparesisRight MCA Ischemic Stroke with Left Hemiparesis
Right MCA Ischemic Stroke with Left Hemiparesis
Azimah Hassan
 
105275305 case-study-peds
105275305 case-study-peds105275305 case-study-peds
105275305 case-study-peds
homeworkping7
 
161144815 obesity
161144815 obesity161144815 obesity
161144815 obesity
homeworkping7
 
163971199 case-report-i
163971199 case-report-i163971199 case-report-i
163971199 case-report-i
homeworkping7
 
109258193 case-ckd
109258193 case-ckd109258193 case-ckd
109258193 case-ckd
homeworkping7
 
205832087 cc-2
205832087 cc-2205832087 cc-2
205832087 cc-2
homeworkping7
 
102901204 case-3
102901204 case-3102901204 case-3
102901204 case-3
homeworkping7
 
163401639 constitution-cases
163401639 constitution-cases163401639 constitution-cases
163401639 constitution-cases
homeworkping7
 
108459462 chapter-7
108459462 chapter-7108459462 chapter-7
108459462 chapter-7
homeworkping7
 
205073848 transpo-11-20
205073848 transpo-11-20205073848 transpo-11-20
205073848 transpo-11-20
homeworkping7
 
106826880 cc-update-09-24-12
106826880 cc-update-09-24-12106826880 cc-update-09-24-12
106826880 cc-update-09-24-12
homeworkping7
 
163236411 dena-case-study
163236411 dena-case-study163236411 dena-case-study
163236411 dena-case-study
homeworkping7
 
206569099 ben-final-case-study-osmak
206569099 ben-final-case-study-osmak206569099 ben-final-case-study-osmak
206569099 ben-final-case-study-osmak
homeworkping7
 
206361986 cases-ethics
206361986 cases-ethics206361986 cases-ethics
206361986 cases-ethics
homeworkping7
 

Viewers also liked (20)

Medical case report_ravi_chang_final
Medical case report_ravi_chang_finalMedical case report_ravi_chang_final
Medical case report_ravi_chang_final
 
Ischemic and hemorrhagic stroke
Ischemic and hemorrhagic strokeIschemic and hemorrhagic stroke
Ischemic and hemorrhagic stroke
 
Ischemic stroke
Ischemic strokeIschemic stroke
Ischemic stroke
 
ischemic stroke
ischemic strokeischemic stroke
ischemic stroke
 
Ischemic Stroke Subclassification, An Asian Viewpoint
Ischemic Stroke Subclassification, An Asian ViewpointIschemic Stroke Subclassification, An Asian Viewpoint
Ischemic Stroke Subclassification, An Asian Viewpoint
 
Hemorrhagic stroke final final
Hemorrhagic stroke   final finalHemorrhagic stroke   final final
Hemorrhagic stroke final final
 
Right MCA Ischemic Stroke with Left Hemiparesis
Right MCA Ischemic Stroke with Left HemiparesisRight MCA Ischemic Stroke with Left Hemiparesis
Right MCA Ischemic Stroke with Left Hemiparesis
 
105275305 case-study-peds
105275305 case-study-peds105275305 case-study-peds
105275305 case-study-peds
 
161144815 obesity
161144815 obesity161144815 obesity
161144815 obesity
 
163971199 case-report-i
163971199 case-report-i163971199 case-report-i
163971199 case-report-i
 
109258193 case-ckd
109258193 case-ckd109258193 case-ckd
109258193 case-ckd
 
205832087 cc-2
205832087 cc-2205832087 cc-2
205832087 cc-2
 
102901204 case-3
102901204 case-3102901204 case-3
102901204 case-3
 
163401639 constitution-cases
163401639 constitution-cases163401639 constitution-cases
163401639 constitution-cases
 
108459462 chapter-7
108459462 chapter-7108459462 chapter-7
108459462 chapter-7
 
205073848 transpo-11-20
205073848 transpo-11-20205073848 transpo-11-20
205073848 transpo-11-20
 
106826880 cc-update-09-24-12
106826880 cc-update-09-24-12106826880 cc-update-09-24-12
106826880 cc-update-09-24-12
 
163236411 dena-case-study
163236411 dena-case-study163236411 dena-case-study
163236411 dena-case-study
 
206569099 ben-final-case-study-osmak
206569099 ben-final-case-study-osmak206569099 ben-final-case-study-osmak
206569099 ben-final-case-study-osmak
 
206361986 cases-ethics
206361986 cases-ethics206361986 cases-ethics
206361986 cases-ethics
 

Similar to 205804404 ischemic-stroke-case-study

163362155 case-analysis
163362155 case-analysis163362155 case-analysis
163362155 case-analysis
homeworkping7
 
210489573 62553270-case-study-on-chronic-kidney-disease
210489573 62553270-case-study-on-chronic-kidney-disease210489573 62553270-case-study-on-chronic-kidney-disease
210489573 62553270-case-study-on-chronic-kidney-disease
homeworkping8
 
Case study of TOF
Case study of TOFCase study of TOF
Case study of TOF
grimioire
 
Running head SKIN CONDITIONS AND DIFFERENTIAL DIAGNOSIS 1SKIN.docx
Running head SKIN CONDITIONS AND DIFFERENTIAL DIAGNOSIS 1SKIN.docxRunning head SKIN CONDITIONS AND DIFFERENTIAL DIAGNOSIS 1SKIN.docx
Running head SKIN CONDITIONS AND DIFFERENTIAL DIAGNOSIS 1SKIN.docx
jeanettehully
 
82085243 case-study-on-pregnancy-induced-hypertension-eclampsia
82085243 case-study-on-pregnancy-induced-hypertension-eclampsia82085243 case-study-on-pregnancy-induced-hypertension-eclampsia
82085243 case-study-on-pregnancy-induced-hypertension-eclampsia
homeworkping3
 
85315206 case-study-1
85315206 case-study-185315206 case-study-1
85315206 case-study-1
homeworkping3
 
EPIGASTRIC PAIN
EPIGASTRIC PAINEPIGASTRIC PAIN
EPIGASTRIC PAIN
charmaineBallano3
 
Physical diagnosis
Physical diagnosis Physical diagnosis
Physical diagnosis
MelPajantoy
 
History and PE
History and PEHistory and PE
History and PE
MelPajantoy
 
PKD-PRESENTATION.pptx
PKD-PRESENTATION.pptxPKD-PRESENTATION.pptx
PKD-PRESENTATION.pptx
TheWest3
 
~$Tongue, face and body diagnosis (warning)
~$Tongue, face and body diagnosis (warning)~$Tongue, face and body diagnosis (warning)
~$Tongue, face and body diagnosis (warning)
audrygodwyn
 
Nc process geria
Nc process geriaNc process geria
Nc process geriaJennan R.
 
59866419 case-study-cva
59866419 case-study-cva59866419 case-study-cva
59866419 case-study-cva
homeworkping4
 
Name Pt. Encounter Number Date Age Sex SUBJ.docx
Name    Pt. Encounter Number Date  Age  Sex  SUBJ.docxName    Pt. Encounter Number Date  Age  Sex  SUBJ.docx
Name Pt. Encounter Number Date Age Sex SUBJ.docx
pauline234567
 
206385498 stab-wound
206385498 stab-wound206385498 stab-wound
206385498 stab-wound
homeworkping7
 
82838902 case-study-on-dengue
82838902 case-study-on-dengue82838902 case-study-on-dengue
82838902 case-study-on-dengue
homeworkping3
 
SOAP NOTEName  C.M.Date 04082016Time 1055Pt. Encount.docx
SOAP NOTEName  C.M.Date 04082016Time 1055Pt. Encount.docxSOAP NOTEName  C.M.Date 04082016Time 1055Pt. Encount.docx
SOAP NOTEName  C.M.Date 04082016Time 1055Pt. Encount.docx
rosemariebrayshaw
 
Case history for dental students
Case history for dental students Case history for dental students
Case history for dental students
Muskan Hinduja
 
Clinicopathological Conference.pptx
Clinicopathological Conference.pptxClinicopathological Conference.pptx
Clinicopathological Conference.pptx
iftikhar97
 

Similar to 205804404 ischemic-stroke-case-study (20)

163362155 case-analysis
163362155 case-analysis163362155 case-analysis
163362155 case-analysis
 
210489573 62553270-case-study-on-chronic-kidney-disease
210489573 62553270-case-study-on-chronic-kidney-disease210489573 62553270-case-study-on-chronic-kidney-disease
210489573 62553270-case-study-on-chronic-kidney-disease
 
6. age
6. age6. age
6. age
 
Case study of TOF
Case study of TOFCase study of TOF
Case study of TOF
 
Running head SKIN CONDITIONS AND DIFFERENTIAL DIAGNOSIS 1SKIN.docx
Running head SKIN CONDITIONS AND DIFFERENTIAL DIAGNOSIS 1SKIN.docxRunning head SKIN CONDITIONS AND DIFFERENTIAL DIAGNOSIS 1SKIN.docx
Running head SKIN CONDITIONS AND DIFFERENTIAL DIAGNOSIS 1SKIN.docx
 
82085243 case-study-on-pregnancy-induced-hypertension-eclampsia
82085243 case-study-on-pregnancy-induced-hypertension-eclampsia82085243 case-study-on-pregnancy-induced-hypertension-eclampsia
82085243 case-study-on-pregnancy-induced-hypertension-eclampsia
 
85315206 case-study-1
85315206 case-study-185315206 case-study-1
85315206 case-study-1
 
EPIGASTRIC PAIN
EPIGASTRIC PAINEPIGASTRIC PAIN
EPIGASTRIC PAIN
 
Physical diagnosis
Physical diagnosis Physical diagnosis
Physical diagnosis
 
History and PE
History and PEHistory and PE
History and PE
 
PKD-PRESENTATION.pptx
PKD-PRESENTATION.pptxPKD-PRESENTATION.pptx
PKD-PRESENTATION.pptx
 
~$Tongue, face and body diagnosis (warning)
~$Tongue, face and body diagnosis (warning)~$Tongue, face and body diagnosis (warning)
~$Tongue, face and body diagnosis (warning)
 
Nc process geria
Nc process geriaNc process geria
Nc process geria
 
59866419 case-study-cva
59866419 case-study-cva59866419 case-study-cva
59866419 case-study-cva
 
Name Pt. Encounter Number Date Age Sex SUBJ.docx
Name    Pt. Encounter Number Date  Age  Sex  SUBJ.docxName    Pt. Encounter Number Date  Age  Sex  SUBJ.docx
Name Pt. Encounter Number Date Age Sex SUBJ.docx
 
206385498 stab-wound
206385498 stab-wound206385498 stab-wound
206385498 stab-wound
 
82838902 case-study-on-dengue
82838902 case-study-on-dengue82838902 case-study-on-dengue
82838902 case-study-on-dengue
 
SOAP NOTEName  C.M.Date 04082016Time 1055Pt. Encount.docx
SOAP NOTEName  C.M.Date 04082016Time 1055Pt. Encount.docxSOAP NOTEName  C.M.Date 04082016Time 1055Pt. Encount.docx
SOAP NOTEName  C.M.Date 04082016Time 1055Pt. Encount.docx
 
Case history for dental students
Case history for dental students Case history for dental students
Case history for dental students
 
Clinicopathological Conference.pptx
Clinicopathological Conference.pptxClinicopathological Conference.pptx
Clinicopathological Conference.pptx
 

More from homeworkping7

207797480 effective-study-skills-3
207797480 effective-study-skills-3207797480 effective-study-skills-3
207797480 effective-study-skills-3
homeworkping7
 
207745685 b-777-oral-study
207745685 b-777-oral-study207745685 b-777-oral-study
207745685 b-777-oral-study
homeworkping7
 
207702106 spec-pro-cases
207702106 spec-pro-cases207702106 spec-pro-cases
207702106 spec-pro-cases
homeworkping7
 
207619526 urc-case-study
207619526 urc-case-study207619526 urc-case-study
207619526 urc-case-study
homeworkping7
 
207528705 family-case-study-1
207528705 family-case-study-1207528705 family-case-study-1
207528705 family-case-study-1
homeworkping7
 
207492751 examples-of-unethical-behavior-in-the-workplace
207492751 examples-of-unethical-behavior-in-the-workplace207492751 examples-of-unethical-behavior-in-the-workplace
207492751 examples-of-unethical-behavior-in-the-workplace
homeworkping7
 
207402181 ee-ass1
207402181 ee-ass1207402181 ee-ass1
207402181 ee-ass1
homeworkping7
 
207372012 long-case-rawalo-dedi
207372012 long-case-rawalo-dedi207372012 long-case-rawalo-dedi
207372012 long-case-rawalo-dedi
homeworkping7
 
207287040 a-study-on-impact-of-ites-sectors-in-india
207287040 a-study-on-impact-of-ites-sectors-in-india207287040 a-study-on-impact-of-ites-sectors-in-india
207287040 a-study-on-impact-of-ites-sectors-in-india
homeworkping7
 
207285085 classic-knitwear-case-study
207285085 classic-knitwear-case-study207285085 classic-knitwear-case-study
207285085 classic-knitwear-case-study
homeworkping7
 
207244508 united-color-of-benaton
207244508 united-color-of-benaton207244508 united-color-of-benaton
207244508 united-color-of-benaton
homeworkping7
 
207137236 ee2207-lm
207137236 ee2207-lm207137236 ee2207-lm
207137236 ee2207-lm
homeworkping7
 
207135483 oblicon-case-digestsxavier
207135483 oblicon-case-digestsxavier207135483 oblicon-case-digestsxavier
207135483 oblicon-case-digestsxavier
homeworkping7
 
207095812 supply-chain-management
207095812 supply-chain-management207095812 supply-chain-management
207095812 supply-chain-management
homeworkping7
 
207043126 ikea-case-study-solution
207043126 ikea-case-study-solution207043126 ikea-case-study-solution
207043126 ikea-case-study-solution
homeworkping7
 
206915421 avatar-case-study
206915421 avatar-case-study206915421 avatar-case-study
206915421 avatar-case-study
homeworkping7
 
206891661 ee2002-lab-manual-fall-2013
206891661 ee2002-lab-manual-fall-2013206891661 ee2002-lab-manual-fall-2013
206891661 ee2002-lab-manual-fall-2013
homeworkping7
 
206885611 eskom-ee-simama-ranta-2014
206885611 eskom-ee-simama-ranta-2014206885611 eskom-ee-simama-ranta-2014
206885611 eskom-ee-simama-ranta-2014
homeworkping7
 
206883782 lawyers-fiduciary-obligations
206883782 lawyers-fiduciary-obligations206883782 lawyers-fiduciary-obligations
206883782 lawyers-fiduciary-obligations
homeworkping7
 
206869083 ortho-study-guide
206869083 ortho-study-guide206869083 ortho-study-guide
206869083 ortho-study-guide
homeworkping7
 

More from homeworkping7 (20)

207797480 effective-study-skills-3
207797480 effective-study-skills-3207797480 effective-study-skills-3
207797480 effective-study-skills-3
 
207745685 b-777-oral-study
207745685 b-777-oral-study207745685 b-777-oral-study
207745685 b-777-oral-study
 
207702106 spec-pro-cases
207702106 spec-pro-cases207702106 spec-pro-cases
207702106 spec-pro-cases
 
207619526 urc-case-study
207619526 urc-case-study207619526 urc-case-study
207619526 urc-case-study
 
207528705 family-case-study-1
207528705 family-case-study-1207528705 family-case-study-1
207528705 family-case-study-1
 
207492751 examples-of-unethical-behavior-in-the-workplace
207492751 examples-of-unethical-behavior-in-the-workplace207492751 examples-of-unethical-behavior-in-the-workplace
207492751 examples-of-unethical-behavior-in-the-workplace
 
207402181 ee-ass1
207402181 ee-ass1207402181 ee-ass1
207402181 ee-ass1
 
207372012 long-case-rawalo-dedi
207372012 long-case-rawalo-dedi207372012 long-case-rawalo-dedi
207372012 long-case-rawalo-dedi
 
207287040 a-study-on-impact-of-ites-sectors-in-india
207287040 a-study-on-impact-of-ites-sectors-in-india207287040 a-study-on-impact-of-ites-sectors-in-india
207287040 a-study-on-impact-of-ites-sectors-in-india
 
207285085 classic-knitwear-case-study
207285085 classic-knitwear-case-study207285085 classic-knitwear-case-study
207285085 classic-knitwear-case-study
 
207244508 united-color-of-benaton
207244508 united-color-of-benaton207244508 united-color-of-benaton
207244508 united-color-of-benaton
 
207137236 ee2207-lm
207137236 ee2207-lm207137236 ee2207-lm
207137236 ee2207-lm
 
207135483 oblicon-case-digestsxavier
207135483 oblicon-case-digestsxavier207135483 oblicon-case-digestsxavier
207135483 oblicon-case-digestsxavier
 
207095812 supply-chain-management
207095812 supply-chain-management207095812 supply-chain-management
207095812 supply-chain-management
 
207043126 ikea-case-study-solution
207043126 ikea-case-study-solution207043126 ikea-case-study-solution
207043126 ikea-case-study-solution
 
206915421 avatar-case-study
206915421 avatar-case-study206915421 avatar-case-study
206915421 avatar-case-study
 
206891661 ee2002-lab-manual-fall-2013
206891661 ee2002-lab-manual-fall-2013206891661 ee2002-lab-manual-fall-2013
206891661 ee2002-lab-manual-fall-2013
 
206885611 eskom-ee-simama-ranta-2014
206885611 eskom-ee-simama-ranta-2014206885611 eskom-ee-simama-ranta-2014
206885611 eskom-ee-simama-ranta-2014
 
206883782 lawyers-fiduciary-obligations
206883782 lawyers-fiduciary-obligations206883782 lawyers-fiduciary-obligations
206883782 lawyers-fiduciary-obligations
 
206869083 ortho-study-guide
206869083 ortho-study-guide206869083 ortho-study-guide
206869083 ortho-study-guide
 

Recently uploaded

special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 

Recently uploaded (20)

special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 

205804404 ischemic-stroke-case-study

  • 1. Get Homework/Assignment Done Homeworkping.com Homework Help https://www.homeworkping.com/ Research Paper help https://www.homeworkping.com/ Online Tutoring https://www.homeworkping.com/ click here for freelancing tutoring sites
  • 2. Ischemic Stroke Case Study January 2014 1. Basis of selection of case In the previous years, a Food and Nutrition Research Institute 1998 study, about 21 percent of adults aging from 20 years old and above have hypertension, (the single
  • 3. most important risk factor for stroke and it causes about 50 per cent of ischemic strokes and also increases the risk of hemorrhagic stroke) while a Philippine Health Statistics 1993 figure showed 28 deaths per 100 000 population caused by stroke. Nowadays, still, stroke makes its way on top. Worldwide, stroke is the second- leading cause of death after heart disease and is also a big contributor to disability. Due to the increasing number of stroke cases annually and the expanding cases in the younger generation, the government of the Philippines should emphasize primary and secondary prevention strategies. As we talk about prevention strategies, there is a great role for nurses/student nurses, as well as for the rest of the medical team, comes in. Reading a case study and coming up with a diagnosis is a good way for nursing students to test the knowledge they've acquired in the classroom in a more realistic, clinical way. Writing case studies is also a useful learning tool; it forces students to reflect on the entire course of treatment for a patient, ranging from obtaining important information to diagnosis to treating the medical condition. Increasing the knowledge regarding the disease process of stroke, the proper assessment of the patient, correct intervention, effective health teaching, etc will contribute a lot in improving prevention strategies. 2. Clarity of Objectives General Objectives
  • 4. After 2 hours of case presentation, the students will be able to obtain the knowledge to enhance skills and to develop the attitude towards caring of the patient with cases regarding ischemic stroke. Specific Objectives Specifically, this aims to KNOWLEDGE 1. Explain the pathophysiology of ischemic stroke. 2. Identify the main cause of the disease. 3. Name the signs and symptoms of the disease manifested by the client. SKILLS 1. Carry out independent and dependent intervention being done to the client appropriately and with care. 2. Perform comprehensive nursing interventions based on the client’s priority needs. 3. Demonstrate proper approach used in clients with ischemic stroke. ATTITUDES 1. Establish rapport to the client and folks. 2. Encourage the folks to cooperate to the intervention being performed. 3. Avoid promising words that might worsen the client’s condition. 3.1 ASESSMENT A. PATIENT’S PROFILE
  • 5. NAME: R. C. AGE: 64 years old SEX: Male DATE OF BIRTH: June 28, 1949 ADDRESS: Barotac Viejo, Iloilo OCCUPATION: National Referee, Retired Teacher RELIGION: Roman Catholic NATIONALITY: Filipino ACTIVITY: Moderate Backrest CC: Stiffening of extremities DATE OF ADMISSION: December 12, 2013 DIAGNOSIS: T/C Brain Mets v/s restroke prob. Bleed, S/P CVD with no residuals (2013) HCVD R/O Metastatic cause DM 2- NIR S/P Thyroidectomy for thyroid CA Stage 1 PHYSICIAN: Dr. A B. NURSING HISTORY
  • 6. I. Reason for Seeking Care Stiffening of extremities II. Present Health History Patient R.C. is 64 years old, male and married. He is a retired teacher and a national referee. 8 months prior to admission, patient experienced episode of syncope. He was then admitted at St. Paul’s Hospital for 1 month and managed as CVP, no residual noted. 1 month prior to admission, undocumented fever was noted. He was admitted at Don Ramon Tugbang Medical Center and diagnosed to have Urinary Tract Infection. On the day of admission, patient experienced generalized weakness and stiffening of extremities. A complaint of dizziness was noted. He was responsive and slurring of speech is noted. He was brought to Don Ramon Tugbang Medical Center and then referred at Iloilo Mission Hospital. III. Past Health History
  • 7. It was known that he is hypertensive and have Diabetes Mellitus. He has many previous hospitalizations. He was diagnosed to have thyroid cancer stage 1 back in 1986. He had undergone radiation therapy and left thyroidectomy in the same year at Philippine General Hospital. No known allergies. Last December 2012, He underwent Cranial CT scan and CT scan with contrast. January 7, 2014, he again underwent cranial CT scan. IV. Current Medication For now, he has current medication such as Amlodopine 10mg/tab OD, Simvastatin 40 mg/tab OD, Losartan 50 mg/tab 1 tab OD for his hypertension and Metformin 500 mg 1 tab OD for his Diabetes Mellitus. V. Lifestyle He is non-smoker and non-alcoholic drinker. He is also an athletic person. As verbalized by the wife, most of the time he ate carrots instead of rice. VI. Family History As verbalized by the wife, he has familial history of Hypertension and Diabetes Mellitus. C. PHYSICAL ASESSMENT
  • 8. VITAL SIGNS R.C.’s temperature is 36.5 °C, pulse rate is 88 beats per minute, respiratory rate is 20 breaths per minute, and blood pressure is 180/100 mmHg. GENERAL APPEARANCE R.C. is a 64 year old male, a national referee and a retired teacher. Bedridden since the day of admission. Ectomorph, well developed and appears to be at stated age. Well cleaned and wears appropriate clothes. Difficulty or discomfort making laryngeal speech sounds or varying volume, quality, or pitch of speech. Comprehends directions. Appears to be in distress. SKIN Brown in color, dry, and wrinkled due to old age.Peeling, scaly and flaky skin on heels of the feet. Skin color differences among body areas and between sun-exposed and non-sun-exposed areas. Darker skin around elbows and knees. Warm in temperature. Turgor resilience. Bilateral symmetry. Hair present on scalp, lower face, nares, chest, legs, and pubic areas. NAILS Nails beds pink with varying opacity. Short, squoval, smooth, flat, with edges smooth and round, Longitudinal ridging and beading. Hard and firm with uniform thickness. Well-groomed and uniform without deformities. Good capillary refill. HEAD AND FACE
  • 9. Hair is short, black with minimal gray hairs, and distributed evenly. Hair strands are thin, fine and silky. Head is midline. Skull normocephalic, symmetric and without deformities. Scalp is intact and without lesions or mass noted. Temporal pulses palpable. No bruits. Presence of beard on upper lip and chin. Presence of black heads on the nose. Presence of dimple at the right side of the face. EYES Eyebrows are smooth, black in color and distributed evenly and in line with each other. With mole noted on the left inner end of the brow.Superior eyelid covering a portion of iris when open. Eyelashes are black, evenly distributed, present on both lids and turned outward. Conjunctivae pink, sclera anecteric. Irides black. Pupils equal, round, and reactive to light and accommodation. EARS Auricles in alignment, same color as facial skin.Firm and mobile, readily coiling from position; non-tender.Absence of discharges. NOSE Nose in midline, no discharges or polyps, mucosa pink and moist, septum midline, patent bilaterally. Conforms to face to color.Nares oval and symmetrically positioned. No sinus tenderness to palpation. With O2 at 2Lpm via nasal cannula. MOUTH AND OROPHARYNX
  • 10. Lips symmetric vertically and horizontally at rest and moving.Dry, bluish purple, distinct border between lips and facial skin. Teeth are stained yellow and absence of left lateral incisor. Gingiva pink and moist. Tongue is midline, dull red in color and moist. No tremors and fasciculation. Hard palate and soft palate are pinkish in color. Pharynx clear without erythema. Uvula rises evenly. NECK Neck is straight and symmetrical. Trachea midline. Jugular vein distention noted. Carotid pulse palpable.Cricoid cartilages smooth and moves during swallowing. Left thyroid palpable, firm, and smooth; presence of slightly hypoechoic nodule.Absence of right thyroid lobe. THORAX AND CHEST Minimal increase in the anteroposterior diameter of chest.Thoracic expansion symmetric. No adventitious breath sounds. Regular respiratory rate. Chest retraction noted. Apical pulse on 5th intercostals space. The areola and nipples are dark brown in color and no discharges noted. ABDOMEN Soft, flat and symmetrical. Uniform in color, no pigmentation and rashes noted. No abdominal scars and masses. Active bowel sounds audible in four quadrants. UPPER EXTREMITIES
  • 11. Arms fair in color and symmetrical. No tenderness upon palpation of muscle and joints. Unable to passively perform full range of motion at right affected hand; stiffness noted. Palms are pale and warm. Radial and brachial pulses palpable.With PNSS 1L x 80cc/H infusing well at left cephalic vein. LOWER EXTREMITIES Legs are fair in color and symmetrical. Muscles are firm and skin is slightly dry. Soles are pale and warm to touch. Unable to passively perform full range of motion at right affected leg. Popliteal and dorsalis pedis pulses palpable. GENITO-ANAL AND GENITO-URINARY Pubic hairs are present. No skin lesions, penile discharges and swelling noted. Urinated to a moderate amount of yellowish colored urine.Defecated to a soft brown stool. D. DIAGNOSTIC TEST
  • 12. LABORATORY TEST RESULT NORMAL VALUES SIGNIFICANCE URINALYSIS  Color Pale straw  Transparency Slightly Hazy  Reaction 7.0  Specific Gravity 1.015 1.010 – 1.025 NORMAL  Sugar 1+  Albumin Neg ( - )  Pus cells 3.6 hpf  Red Bloodcells 0.3 hpf  Amorphous urates FEW  Squamous Cells FEW  Bacteria Occasional  Mucus Threads FEW  Yeast Cells NONE HEMATOLOGY  Hemoglobin 103 g/L 140 – 180 Anemia, bleeding, blood dyscrasia  Hematocrit 0.31 vol.fr. 0.42- 0.52 Anemia  Red bloodcell count 3.77 x 10^ 12/L 4.7 – 6.1 Anemia, bleeding, bone marrow failure, malnutrition  White bloodcell count 14.98 x 10 ^9/ L 5.2 -12.4 Infection, Anemia, adrenal or thyroid gland issues, immune system disorder, inflammation, tissue damage, severe stress  Segmenter 90% 50 – 70 infection, inflammation  Stab 0 2-5  Juvenile 0 0 - 1 Normal
  • 13.  Basinophil 0 0.0 – 1.5 Normal  Eosinophil 0 0 – 7 Normal  Lymphocyte 9% 19 – 48 not significant  Monocyte 1% 3.4 – 9 not significant  Platelet Count 341 x 10^9/ L 130 – 400 Normal  MCV 83 fl 80 – 94 Normal  MCH 27 pq 27 – 31 Normal  MCHC 33g/dL 33 – 37 Normal  RDW 11.7% 11.5 – 14.5 Normal  ESR 37 mm/ Hr 0 – 10 inflammation IMMUNOLOGY  CRP 48 mg/L <6- inflammation  T3 95nmol/L 0.95 – 250 Normal  T4 91.43 nmol/L 60 – 120 Normal  TSH 0.88 u/ v/mL 0.25 – 5.0 Normal Euthyroid: 0.25 – 5.0u/V/ml Hypothyroid : greater than 7.0u/V/ml Hyperthyroid: less than 0.15u/V/ml  APTT 24.4 sec 24.0 – 35.0 Normal  % Activity 99% 70-100 Normal  Patient 13.1 sec 11.6- 16.0 Normal  INR 1.00 - CHEMISTRY  Fastingbloodsugar 9.58 mmol/L 4.10 – 5.90 heart attack, stroke  Cholesterol 3.44 mmol/L 1.30 – 5.2 Normal  Triglycerides .94 mmol/L 0.17 – 1.70 Normal
  • 14.  HDL 0.84 mmol/L .90 – 1.55 atherosclerosis, CVD  LDL 2.17 mmol/L 0.0 – 3.9 Normal  Uric Acid 178 mmol/L 160-430 Normal  Calcium 2.05 mmol/L 2.12- 2.25 Hypocalcemia ULTRASOUND Thyroid Ultrasound:  The right thyroidlobe is surgically absent. Theleft thyroidmeasures 3.73x 1.63 x 1.29cm ( LxWxAP ). The isthmus is not thickenedandmeasures 0.21mmin thickness. Thereis a slightly hyporechoic nodule notedin the inferior aspect of the left thyroid lobe measuring0.81x 0.71 x 0.53cm ( LxWxAP ). There is a cystic focus notedat the junctionof the isthmus andleft thyroidlobe measuring0.46 x 0.46x 0.26cm ( LxWxAP ). A cystic focus is also notedin the midportion ofthe thyroidlobe measuring0.24x 0.11cm ( WxAP ). The surroundingsoft tissues andvascular structures are unremarkable. No mass/enlargedcervical lymphnodes appreciated. Remarks:  Left thyroidnodule andcyst.  S/P Right thyroidectomy. CHESTX-RAY ChestPA:  Clear lungfield with no grossly evident active koch’s infiltrates  Tracheamidline  Intact costophrenicsinuses  Smooth diaghragmatic leaves  Cardiac silhouettenorenlargedtransversely  Curvilinear calcific densitynotedat the aortic knob  Rest of the visualizedsoft andosseous tissues appear  Unremarkable Impression:  Atherosclerosis: Aorta CTSCAN
  • 15.  Plain andcontrast enhancedaxial tomographicsections of the headreveal inhomogeneously enhancinghypodensitywith gyral enhancement at theright frontoparietal areas. Also note of enhancingisodense nodules lesions withsurroundingedema in the right inferior frontal andright frontal periventricular areas. There are small hypodensities onboth capsuloganghenic andbifrontoparietal periventricularareas. The ventricles areenlarged. The midline structures are displacedto theleft. The cerebral sulci are effaced. No abnormal extra-axial fluidcollectiondemonstrated. No posterior fossa , brain stemandsellar region do not appear unusual. The petromastoids, includedorbits andparancoal sinuses andthe bony calvarium are unremarkable. Remarks:  Right frontoparietalhypodensity withgyral enhancement.  Right inferiorfrontal andright frontal periventricular enhancinglesions withsurroundingedema.  Lacunar infarcts, bilateral capsuloganglionicbifrontoparietal periventricular areas.  Leftwardsubfalcine herniation.  Obstructive hydrocephalus. Drug Therapy Generic name:Valporic Acid Classification: Anti Convulsant Dosage:( Adult and children > 10 y.o ) = 10- 15 mg/kg/day PO Route: Oral Therapeutic Actions:  Mechanism of action not understood; Anti epileptic activity may be related to the metabolism of inhibitory neurotransmitter, GABA. Indications:  Solo and adjunctive therapy in simple ( petit mal ) and complex absence seizure  Acute treatment of manic episode associated with bipolar disorder  Prophylaxis of migraine headache Contraindication and Cautions:  Contraindicated with hypersensitivity to valporic acid, hepatic disease or significant hepatic impairment  Use cautiously with children younger than 18 months; children younger than 2 y.o Adverse Effects:
  • 16.  CNS: Sedation, emotional upset, depression, psychosis, aggression, behavioral deterioration, suicibility.  SKIN: Hair loss, rash  GI: Nausea, vomiting, indigestion, diarrhea, abdominal cramps, constipation.  GU: Irregular menses, amenorrhea  HEMATOLOGIC: Altered bleeding, bruising. Nursing considerations:  Products containing alcohol should be avoided.  Give drug with food if GI upset occurs.  Be aware that the patient maybe increased risk for suicidal ideation monitor accordingly. Patient Teaching:  Take this drug exactly as prescribed.  Do not chew tablet or capsule before swallowing them.  Do not discontinue this drug abruptly or change dosage.  Avoid alcohol and sleep inducing drugs. Generic name:Losartan Potassium Classification:Angioten II Antagonist Dosage:( Adult and children 6 yrs and older ) = Starting dose of 50 mg PO daily Route: Oral Therapeutic Actions:  Selectively blocks the binding of angiotensin II to specific tissue receptors found in the vascular smooth muscle and adrenal gland. Indications:  Treatment of hypertension, done or combination with other hypertensive.  Treatment of diabetic nephropathy.  Reduction of risk of CVA in patients. Contraindications and Cautions:  Contraindicated in previous hypersensitivity.  Pregnancy or lactation  Reduce dosage with hepatic or renal impairment. Adverse Effects:  CNS: Headache, dizziness and insomnia
  • 17.  CV: Hypertension  SKIN: Rash and dry skin  GI: Diarrhea, abdominal pain and nausea  RESPIRATORY: Cough  OTHER: Back pain, fever and gout Nursing Considerations: Assessment  Hypersensitivity to Losartan  Pregnant  Lactation Patient Teaching:  Take drug without regard to meals  May experience these side effects: - Dizziness - Headache - Nausea and vomiting  Report fever, chills and pregnant Generic name:Metformin Classification:Antidiabetic Agents Drugs:( Adult and pediatric 10 – 16 y.o ) = 500 mg bid/ 250 mg bid Route: Oral Therapeutic Reaction:  Increase peripheral utilization of glucose and decrease hepatic glucose production. Indications:  Adjunct to diet to lower blood glucose with type 2 DM Contraindication and Cautions:  With allergy to metformin, heart failure, diabetes complicated by fever, severe trauma and severe infection.  Use cautiously with the elderly Adverse Effects:  ENDOCRINE: Hypoglycemia  GI: Anorexia, nausea and vomiting  HYPERSENSITIVITY: Allergic skin reaction Nursing Considerations:  Allergy to metformin  Pregnancy  Lactation
  • 18. Patient Teaching:  Monitor blood for glucose and ketones as prescribed.  Do not use this drug during preganancy.  Avoid using alcohol while taking this drug.  Report fever, sore throat, unusual bleeading and bruising. Other anti-diabetic drugs: Gliclazide, Sitagliptin Generic name: Baclofen Classification: Muscle relaxant Dosage: 5 mg PO tid for 3 days Route: Oral Therapeutic Actions:  Inhibits both monosynaptic and polysynaptic spinal reflexes; CNS depressant Indications:  Alleviation of signs and symptoms of spasticity resulting from MS  Spinal cord injuries and other spinal cord diseases Contraindications and Cautions:  Contraindicated in previous hyper sensitivity.  With skeletal muscle spasm  Use cautiously with strokes, cerebral palst, parkinson’s disease  Lactation and pregnancy Adverse Effects:  CNS: Transient drowsiness, weakness, fatigue  CV: Hypotension  GI: Nausea, Constipation  GU: Urinary frequency, dysuria  OTHER: Rash, pruritus, ankle edema Nursing Considerations:  Discontinue drug if hypersensitivity reaction occur  Lactation  Evaluate therapeutic response Patient Teachings:  Take this drug exactly as prescribed  Avoid alcohol  Do not take this during pregnancy
  • 19. Generic Name: Amlodipine Classification:Antianginal; Antihypertensive; Calcium channel blocker Dosage: Adult and Pediatric 6-17 y.o. 2.5-5 mg daily Route: Oral Therapeutic actions:  Inhibits the movement of calcium ions across the membranes of cardiac cells; inhibits transmembrane calcium flow, w/c result in depression of impulse formation in specialized cardiac pacemaker cells, slowing velocity of conduction of the cardiac impulse. Indications:  Angina pectoris due to coronary artery spasm(Prinzmetal’s Variant angina)  Essential hypertension Contraindications and cautions:  Contraindicated w/ allergy to amlodipine  Use cautiously w/ heart failure  Pregnancy Adverse effects:  CNS: Dizziness, headache, and fatigue  CV: Peripheral edema
  • 20.  Skin; Flushing, rash  GI: Nausea, abdominal discomfort Nursing Consideration:  Administer drug w/out regards to meals  Monitor BP carefully Patient teachings:  Take w/ meals if upset stomach occurs  Report irregular heartbeat, shortness of breath, and constipation Generic name: Diazepam 5 mg IV Classification: Antiepileptic; Anxiolytic Dosage: Usual dosage is 2-20 mg IM/IV Route: IM/IV Therapeutic actions:  Acts mainly as the limbic system and reticular formation; may act in spinal cord and at supraspinal sites to produce skeletal muscle relaxation Indications:  Management of anxiety d/o  Acute alcohol withdrawal  Muscle relaxant Contraindications and cautions:  Contraindicated w/ hypersensitivity to benzodiazepines  Use cautiously w/ elderly, impaired renal function Adverse effects:  CNS: Sedation, depression, fatigue, and restlessness  CV: Bradycardia, CV collapse, and hypertension  Skin: Rash and dermatitis  GI: Constipation and diarrhea  GU: Urinary retention  Hematologic: Decreased Hct  Other: Phlebitis and thrombosis in IV site, fever, diaphoresis, and muscular disturbances
  • 21. Nursing considerations:  Hypersensitivity to benzodiazepines  Pregnancy and lactation  Carefully monitor P, BP, respiration, during IV administration Patient teachings:  Take this drug exactly as prescribed  Tell patient to report drowsiness, and weakness Generic name: Mannitol Classification: Osmotic; Urinary irrigant Dosage: 50-200g/day Route: IV Therapeutic actions:  Elevates the osmolarity of the glomerular filtrate, thereby hindering the reabsortion of water leading to a loss of water, sodium, chloride: creates an osmotic gradient in the eye between plasma and ocular fluids thereby reducing IOP. Indications:  Prevention and treatment of oliguric phase of renal failure  Promotion of urinary excretion of toxic substances  Irrigant in transurethral prostatic resection Contraindications and cautions:  Contraindicated w/ anuria due to severe renal disease  Use cautiously w/ pulmonary congestion, dehydration, heart failure  Lactation  Pregnancy Adverse effects:  CNS: Dizziness, headache , blurred vision, SEIZURES  CV: Hypertension, edema, thrombophlebitis and chest pain  Skin: Skin necrosis w/ infiltration  GI: Nausea, dry mouth  GU: Diuresis, urine retention  Hematologic: Fluid and electrolyte imbalance  Respiratory: Pulmonary congestion
  • 22. Nursing Considerations:  Do not expose solution to low temp crystallization may occur  Make sure infusion set contains a filter if giving concentrated mannitol  Monitor serum electrolytes periodically w/ prolonged therapy Patient teachings:  Patient may experience these side effects: Increased urination, GI upset, dry mouth, headache, blurred vision- ask for assistance  Report difficulty of breathing, pain at the IV site and chest pain Generic name: Simvastatin Classification:Antihyperlipidemic Dosage: 20-40 up to 80 mg PO daily in the evening Route: Oral Therapeutic actions:  Inhibits HMG-CoA reductase, the enzyme that catalyze the first step in the cholesterol synthesis pathway Indications:  To reduce the risk of coronary disease  Treatment of patients w/ isolated hyper triglyceridemia  Treatment of type III hyperlipoproteinemia Contraindications and cautions:  Contraindicated w/ allergy to simvastatin  Use cautiously w/ impaired hepatic and renal function  Cataracts Adverse effects:  CNS: Headache, sleep disturbances  GI: Flatulence, diarrhea, abdominal cramps, constipation, nausea, heartburn, LIVER FAILURE  Respiratory: Sinusitis  Other: ACUTE RENAL FAILURE, myalgia Nursing considerations:  Allergy to simvastasin  Give in evening; highest rate of cholesterol synthesis are bet midnight and 5 am
  • 23.  Advise patient that this drug cannot be taken during pregnancy Patient teachings:  Take drug in the evening  Patient may experience these side effects: Nausea, headache, muscle and joint pains, sensitivity to light  Report severe GI upset, changes in vision, unusual bleeding/bruising, dark urine or light colored stool, fever, muscle pain or soreness E. Pathophysiology Stroke or cerebrovascular accident also known as the brain attack is a vascular disorder that injures the brain function. Stroke remains one of the leading causes of mortality and morbidity. The term brain attack has become a popular substitute for stroke, with the intent of equating stroke with a heart attack in terms of the timetable associated with the development of neurologic deficits and the need for prompt emergency treatment. A brain attack is a sudden impairment of cerebral circulation in one or more blood vessels. It occurs when a blood clot blocks the blood flow in a vessel or artery or when a blood vessel breaks, interrupting blood flow to an area of the brain. Regardless of the cause, the underlying event is deprivation of oxygen and nutrients. Normally, if the arteries become blocked, autoregulatory mechanisms help maintain cerebral circulation until collateral circulation develops to deliver blood to the affected area. If the compensatory mechanism becomes overworked, or if cerebral blood flow remains impaired for more than a few minutes, oxygen deprivation leads to infarction of brain tissue. Stroke interrupts or diminishes oxygen supply and
  • 24. commonly causes serious damage or necrosis in the brain tissues. When either of these things happens, brain cells begin to die. When brain cells die during a stroke, abilities controlled by that area of the brain are lost. These include functions such as speech, movement, and memory. The specific abilities lost or affected depend on the location of the stroke and its severity. There are two types of “brain attacks” – ischemic and hemorrhagic. With ischemic strokes, a blood clot blocks or plugs a blood vessel in the brain. With hemorrhagic strokes, a blood vessel in the brain breaks or ruptures. An ischemic stroke can occur in several ways – embolic, thrombotic, Transient ischemic attack, and lacunar infarcts. Embolic stroke occurs when a blood clots forms in the body (usually the heart) and travels through the blood stream to the brain. Once in the brain, the clot eventually travels to a blood vessel small enough to blocks its passage. The clot lodges there, blocking the blood vessel causing a stroke. In the thrombotic stroke, blood flow is impaired because of the blockage to one or more arteries supplying blood in the brain. Blood-clot strokes can also happen as the result of unhealthy blood vessels clogged with the build up with fatty acids and cholesterol. So your body reacts in these injuries just as it would if you were bleeding from a wound- it responds by forming clots. Transient ischemic attacks, or TIAs, are brief episodes of stroke symptoms resulting from temporary interruptions of blood flow to the brain. It can last anywhere from a few seconds up to 24 hours. Lacunar infarcts are small (1.5 to 2.0 cm) to very small (3 to 4 mm) infarcts located in the deeper noncortical parts of the brain or in the brain stem. They are found in the territory of single deep penetrating arteries supplying the internal capsule, basal ganglia, or brain stem. They result from occlusion of the smaller branches of large
  • 25. cerebral arteries, commonly the middle cerebral and posterior cerebral arteries and less commonly the anterior cerebral, vertebral, or basilar arteries. In the process of healing, lacunar infarcts leave behind small cavities, or lacuna. Six basic causes of lacunar infarcts have been proposed: embolism, hypertension, small-vessel occlusive disease, hematologic abnormalities, small intracranial haemorrhages, and vasospasm. Because of their size and location, lacunar infarcts do not usually cause profound deficits such as aphasia or apracticagnosia of the minor hemisphere. Instead, they often produce syndromes such as pure motor hemiplegia, pure sensory hemiplegia, and dysarthria with the clumsy hand syndrome. Overview The Neurological System is divided into two major parts: the Central Nervous System (CNS) and the Peripheral Nervous System (PNS). The Central Nervous System is the body’s information headquarters, ultimately regulating nearly all body functions. It CNS includes the brain and spinal cord. The brain processes incoming information from within the body, and outside the body by way of the sensory nerves of sight, touch, smell, sound, and taste. In other words, the brain is where all thinking and decision-making takes place. The spinal cord is the main pathway for information connecting the brain and peripheral nervous system. Electrical impulses travel through the nerves and allow the brain to communicate with the rest of the body.
  • 26. The Peripheral Nervous System is responsible for the remainder of the body. It includes cranial nerves (nerves emerging from the brain), spinal nerves (nerves emerging from the spinal cord) and all the major sense organs. The PNS is divided into the somatic (SNS) and autonomic nervous system (ANS). The Somatic Nervous System (SNS) is responsible for all muscular activities that we consider voluntary or that are within our conscious control. The Autonomic Nervous System (ANS) is responsible for all activities that occur automatically and involuntarily, such as breathing, muscle contractions within the digestive system, and heartbeat. The ANS is further divided into two- the sympathetic and parasympathetic system. The Sympathetic System stimulates cell and organ function. It is activated by a perceived danger or threat: by very strong emotions such as fear, anger or excitement; by intense exercise; or when under large amounts of stress. The Parasympathetic System inhibits cell and organ function. It slows down heart rate, resumes digestion, and increases relaxation throughout the body. The brain is the center of our body functioning. Once it is injured the total functioning of our body will be affected. Physical activities are hampered and other vital organs will also be affected as well. Once vital organs are not in their optimum functioning, it will aggravate the seriousness of the condition of the patient.
  • 27. Space – occupying blood clots put more pressure in the brain tissues The ruptured cerebral The regulatorymechanisms of the brain attempt to maintain equilibrium by increasing BP and ICP. Due to thrombosis, or embolism, someneuronsdie because of lack of oxygen and nutrients Hemorrhagic Infarction of the Cerebral Vessels known as Stroke Tissue injury triggers an inflammatory response whichincreasesintracranial pressure. The injury disrupts metabolism leading to changes in ionic transport, localized acidosis, and free radical formation Calcium,Sodium,water accumulate inthe injured
  • 28. F. Prioritizing Nursing Diagnosis 1. Ineffective Cerebral Tissue Perfusion related to cerebral edema as evidenced by altered level of consciousness, stiffening of extremities, slurred speech 2. Impaired Physical Mobility r/t neuromuscular/musculoskeletal impairment 3. Self-Care Deficit r/t impaired mobility status 4. Disturbed Sensory Perception r/t altered sensory perception 5. Impaired Verbal Communication r/t decreased circulation to the brain
  • 29.
  • 30. Cues Nursing Diagnosis Outcome Criteria Nursing Intervention Rationale Evaluation Discharge Planning Subjective: “ Budlayan siya maghulag kag maluya na ang tuo nga parti sang iya lawas. Nabudlayan sya maghambal daw indi maintindihan.” as verbalized by the folk. Objective:  T–36.5  P - 88  R - 22  BP – 180/100  GCS – 11  Stiffening of extremities  Slurred speech  Ineffective Cerebral Tissue Perfusion related to cerebral edema as evidenced by altered level of consciousness, stiffening of extremities, slurred speech Short Term: After 8 hours of effective nursing intervention the patient will be able to: 1. Demonstrate stable vital signs. 2. Prevent / minimize complications. 3. Daily needs are met either by himself or others. 4. Be free from injury and fall Long Term: After 2 weeks of effective nursing intervention the patient will be able to: 1. Maintain Independent: 1. Determine factors related to individual situation /decreased cerebral perfusion. 2. Monitor/document neurological status frequently and compare with baseline. 3. Monitor vital signs. 4. Provide safety measures 5. Evaluate pupils, noting size, shape, equality, light  Influences choice of interventions.  Assesses trends in level of consciousness (LOC) and useful in determining location, extent, and progression/resolution of CNS damage. May also reveal presence of TIA, which may warn of impending thrombotic CVA.  Monitor Alterations  Prevent falls and injury  Pupil reactions are regulated by the oculomotor (III) cranial PARTIALLY MET Short Term: After 8 hours of effective nursing intervention the patient was partially able to: 1. Demonstrate stable vital signs. 2. Prevent / minimize complications. 3. Daily needs are met either by himself or others. 4. Free from injury and fall Long Term: After 2 weeks of effective nursing intervention the M – Instruct the folks and the patient to take drugs as ordered. Emphasize the importance of taking the drugs at the right timing of intake and right dosage. Explain to patient/folks the adverse effects of the drugs. E – Provide/maintain stress free environment for the client to lessen discomfort. T – Instruct patient to perform exercise treatment given by physical
  • 31. usual/improved level of consciousness, cognition, and motor/sensory function. 2. Increased cerebral function and decrease neurological deficits. reactivity. 6. Assess higher functions, including speech, if patient is alert. 7. Position with head slightly elevated and in neutral position. nerve and are useful in determining whether the brainstem is intact. Pupil size/equality is determined by balance between parasympathetic and sympathetic enervation. Response to light reflects combined function of the optic (II) and oculomotor (III) cranial nerves  Changes in cognition and speech content are an indicator of location/degree of cerebral involvement and may indicate deterioration/increased ICP.  Reduces arterial pressure by promoting venous drainage and may improve cerebral patient was partially able to: 1. Maintain usual/improved level of consciousness, cognition, and motor/sensory function. 2.Increased cerebral function and decrease neurological deficits. therapist. Advice folks to assist patient. H – Instruct folks to place patient on moderate backrest. Encourage active ROM for unaffected extremities and perform passive ROM for affected extremities. O – Explain to the patient and folks the importance of keeping follow- up appointments with health care providers and to report any untoward signs and symptoms.
  • 32. 8. Maintain bedrest; provide quiet environment; restrict visitors/activities as indicated. Provide rest periods between care activities, limit duration of procedures. Dependent: 1. Administer oxygen at 2 Lpm as ordered. 2. Administer the following as ordered: -Baclofen1tab BID and ValproicAcid -Mannitol circulation/perfusion  Continual stimulation/activity can increase ICP. Absolute rest and quiet may be needed to prevent rebleeding in the case of hemorrhage.  Reduces hypoxemia, which can cause cerebral vasodilation and increase pressure/edema formation.  For skeletal muscle spasticity of spinal &cerebral origin D – Instruct the patient/folks to follow the diet intended for the patient. Healthy and rich in vitamins and minerals. Collaborate with the dietician. S – Encourage folks to provide physical, emotional, financial, and spiritual support to the patient.
  • 33. 25cc IV q8H -Levetriacetam 500mg 1tab OD -Losartan 50mg/tab 1tab OD -Citicoline 500mg 1tab BID -Amlodipine 20mg 1tab OD -Simvastatin 40mg/tab 1tab OD  To increase urine flow in patients w/ acute renal failure, reduce raised intracranial pressure & treat cerebral edema.  Adjunctive therapy in the treatment of partial seizures w/ or w/o secondary generalization.  To manage HTN  To treat cerebrovascular disorders including ischemic stroke, Parkinsonism & head injury.  To manage HTN & angina pectoris.  To treatment hyperlipidemia; prophylaxis in hypercholesterolemic patients w/ ischemic heart disease.